Bloodstream yeast infections in a university hospital in Northeast Turkey: A 4-year survey

Medical Mycology

Volumn 49, Issue 3, 2011, Pages 316-319

  Aydin, Faruk ^a   Bayramoglu, Gulcin ^a   Guler, Necla Cebeci ^a   Kaklikkaya, Nese ^a   Tosun, Ilknur ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

antifungal resistance; Bloodstream infections; Candida parapsilosis; candidemia

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CLAVISPORA LUSITANIAE; CONTROLLED STUDY; DISK DIFFUSION; DRUG CHOICE; EPSILOMETER TEST; FUNGUS ISOLATION; HEALTH SURVEY; HOSPITALIZATION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SPECIES DISTRIBUTION; TERTIARY HEALTH CARE; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES; TURKEY;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 79952641895     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.512023     Document Type: Article

References (17)

1. Peman J, Canton E, Gobernado M and the Spanish ECMM Working Group on Candidemia. Epidemiology and antifungal susceptibility of Candida species isolates from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 2005; 24: 23-30. (Pubitemid 40179128)
2. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial blood-steam infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317. (Pubitemid 39050477)
3. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: per-sistent public health problem. Clin Microbiol Rev 2007; 20: 133-163. (Pubitemid 46167771)
4. Pfaller MA, Diekema DJ. Twelve years of f uconazole in clinical prac-tice: global trends in species distribution and f uconazole susceptibil-ity of bloodstream isolates of Candida. Clin Microbiol Rev 2004; 10: 11-23. (Pubitemid 38386593)
5. Tavanti A, Davidson AD, Gow NAR, Maiden MCJ, Odds FC. Can-dida orthopsilosis and Candida metapsilosis sp nov. to replace C. parapsilosis Group II and III. J Clin Microbiol 2005; 43: 284-292. (Pubitemid 40096313)
6. Diekema DJ, Messer SA, Hollis RJ, et al. A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. Diagn Microbiol Infect Dis 2009; 63: 233-236.
7. Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2000; 2: 73-85. (Pubitemid 36114141)
8. Cheung C, Guo Y, Gialanella P, Feldmesser M. Development of can-didemia on caspofungin therapy: a case report. Infection 2006; 34: 345-348. (Pubitemid 44968928)
9. Clinical and Laboratory Standards Institute (formerly NCCLS). Ref-erence method for antifungal disk diffusion susceptibility testing of yeasts: Approved standard M44-A.Wayne, PA: Clinical and Labora-tory Standards Institute, 2004.
10. Hobson RP. The global epidemiology of invasive Candida infections-is the tide turning? J Hosp Infect 2003; 55: 159-168. (Pubitemid 37554904)
11. Metwally L, Walker MJ, Coyle P V, et al. Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001-2006. J Infect 2007; 55: 174-178. (Pubitemid 47029751)
12. Sendid B, Cotteau A, Francois N, et al. Candidemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible link. BMC Infect Dis 2006; 6: 80. doi: 10.1186/1471-2334-4-80.
13. Swinne D, Nolard N, Van Rooij P, Detandt M. Bloodstream yeast infections: a 15-month survey. Epidemiol Infect 2009; 1: 1-4.
14. Yapar N, Uysal U, Yucesoy M, Cakir N, Yuce A. Nosocomial blood-stream infections associated with Candida species in a Turkish University Hospital. Mycoses 2006; 49: 134-138.
15. Forrest GN, Weekes E, Johnson JK. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect 2008; 56: 126-129.
16. Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. Prevalence, distribution and antifungal susceptibility pro-f les of Candida parapsilosis, C. orthopsilosis and C. metap-silosis in a Tertiary Care Hospital. J Clin Microbiol 2009; 47: 2392-2397.
17. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Geographic dis-tribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol 2008; 46: 2659-2664.